COVID-19 CP has been used previously in IEI patients and its efficacy is usually evaluated clinically and according to viral load in nasopharyngeal or respiratory tract specimens (42), but evaluation of virus neutralizing capacity in blood in IEI patients is missing (17, 43, 44). Here, CP is linked to COVID-19.